ZEROMET-MYO Tablets

Description

PCOS is the most common endocrine disorder among women between 18 to 44 yrs. 36% of women in India suffer from PCOS. Insulin resistance is a primary cause of PCOS.

Myo-inositol

• Drug class: Insulin-sensitizing agent
• Leads to a decrease in testosterone, triglycerides, and blood pressure.

• Significant improvement in insulin Sensitivity.

• Greatly increased pregnancy of ovulation.

• Myo-inositol decreases both insulin and BMI.

• 50% of 92 PCOS patients exhibited significant weight loss and reduced leptin levels with inositol.

Metformin

• Drug class: Drug class: Biguanides
• Decreases the level of androgens produced by ovaries & adrenal glands

• Helps regulate menstrual cycles, starts ovulation, and leaves the risk of miscarriage in PCOS.

• Also works for women with PCOS who are unresponsive to clomiphene.